Maravai Lifesciences Holdings (MRVI) Short-term Investments (2024)
Maravai Lifesciences Holdings' (MRVI) quarterly Short-term Investments came in at $1.4 million in Q4 2024, down 79.09% quarter-over-quarter from $6.6 million in Q2 2024.
Maravai Lifesciences Holdings (MRVI) Short-term Investments (2024) Analysis & Trends
Maravai Lifesciences Holdings' Short-term Investments history runs 1 years deep, the most recent figure standing at $1.4 million for Q4 2024.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $1.4 million in Q4 2024; TTM through Dec 2024 was $1.4 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.4 million, changed N/A from the prior year.
- Short-term Investments retreated to $1.4 million in Q4 2024 per MRVI's latest filing, from $6.6 million in the prior quarter.
- Across five years, Short-term Investments topped out at $6.6 million in Q2 2024 and bottomed at $1.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.38 Mn |
| Jun 30, 2024 | 6.58 Mn |